4YA-56779-78669 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-08
Dose 1 — Moderna
2021-03-25
Registered in v-safe
2021-03-25
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-29
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-05
Dose 2 — Moderna
2021-04-05
Survey response — day 0, dose 2
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-09
Survey response — days 1–6 daily, dose 2
MedDRA: Cough, Influenza like illness, Respiratory tract congestion — Feeling: Poor · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Cough, congestion, flu like

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-10
Survey response — days 1–6 daily, dose 2
MedDRA: Cough, Influenza like illness, Respiratory tract congestion — Feeling: Poor · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Flu-like congestion, cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-19
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-26
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-03
Survey response — day 28, dose 2
MedDRA: Axillary mass — Feeling: Fair

Free text: Rapidly growing mass in/or/near lymph node in armpit of arm that received the vaccine. First detected 4/29 as hard subcutaneous mass 1/4 in diameter. Is now greater than 1 in diameter. No pain in response to touch or pressure. Contact for Mor

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-10
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-05
Survey response — 3 months, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Still have a ropy, enlarged lymph vessel protruding from my left armpit (first became prominent 3-1/2 weeks after 2nd dose).

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-05
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-08
Call 1 — Left Voicemail
2021-10-04
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-04-05
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-08	Moderna
2	2021-04-05	Moderna

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 6 — day 0, dose 2

2021-04-05

Systemic reaction (other): No

Release 7 — days 1–6 daily, dose 2

2021-04-09

Systemic reaction (other): Cough, congestion, flu like

2021-04-10

Systemic reaction (other): Flu-like congestion, cough

Release 8 — day 28, dose 2

2021-05-03

Symptoms: Rapidly growing mass in/or/near lymph node in armpit of arm that received the vaccine. First detected 4/29 as hard subcutaneous mass 1/4 in diameter. Is now greater than 1 in diameter. No pain in response to touch or pressure. Contact for Mor

Release 9 — 3 months, dose 2

2021-07-05

Symptoms: Still have a ropy, enlarged lymph vessel protruding from my left armpit (first became prominent 3-1/2 weeks after 2nd dose).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Axillary mass	✓	✓	✓
SD	Lymphadenopathy	✓	✓	✓
SRO	Cough	✓	✓	✓
SRO	Influenza like illness	✓	✓	✓
SRO	No adverse event	✓	✓	✓
SRO	Respiratory tract congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release